 |
|
sipuleucel-T
A cell-based vaccine composed of autologous antigen-presenting peripheral blood mononuclear cells (enriched for a dendritic cell fraction) that have been exposed to a recombinant protein consisting of granulocyte-macrophage colony-stimulating factor (GM-CSF) fused to prostatic-acid phosphatase (PAP), a protein expressed by prostate cancer cells. Upon administration, the vaccine may stimulate an antitumor T-cell response against tumor cells expressing PAP. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| US brand name: | | Provenge | | | | Code name: | | APC 8015 | | |
| Previous: | silymarin, Simulect, simvastatin, Singulair, siplizumab | | Next: | siRNA-expressing SV40 vector, sirolimus, sivifene gel, SJG-136, Sk-Dexamethasone |
|
|
